← Back to Search

exercise for Weight Loss

Phase 3
Waitlist Available
Research Sponsored by Kyle Flack
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
overweight to obese (BMI 25-45 kg/m2)
not currently engaged in exercise or weight loss activities
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 minutes after the bout of television watching on the day the participant completed the non-exercise / control arm
Awards & highlights

Study Summary

This trial will take the necessary first steps towards our long-term goal by identifying mechanisms promoting energy intake when exercising for weight loss.

Eligible Conditions
  • Weight Loss
  • Obesity
  • Eating Disorders

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
This group is overweight to obese
Select...
I'm not really doing any exercise or dieting right now.
Select...
Does not have any conditions that affect the heart, lungs, or metabolism.
Select...
The patient is able to engage in safe physical activity.
Select...
This study requires that female participants are premenopausal and not pregnant or nursing.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 minutes after the exercise bout on the day the participant completed the exercise arm
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 minutes after the exercise bout on the day the participant completed the exercise arm for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attentional Bias
Food Reinforcement
Inhibitory Control

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: exerciseExperimental Treatment1 Intervention
exercise treatment performs exercise between being assessed for outcome measures
Group II: controlActive Control1 Intervention
sedentary control group watches TV between being assessed for outcome measures
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
exericse
2021
Completed Phase 3
~40

Find a Location

Who is running the clinical trial?

Kyle FlackLead Sponsor
1 Previous Clinical Trials
42 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
267 Previous Clinical Trials
248,572 Total Patients Enrolled
5 Trials studying Weight Loss
211 Patients Enrolled for Weight Loss

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For patients that are octogenarians, is this clinical study still an option?

"The age requirements for this trial are between 18 and 45 years old. Out of the 934 total trials, 218 were for patients below 18 and 716 were for those over 65."

Answered by AI

Exercise, how risky is it for people?

"Given that this is a Phase 3 trial with some efficacy data as well as multiple rounds of supportive safety data, we rate the safety of Exercise at a 3."

Answered by AI

Are there still open slots for potential participants in this experiment?

"Unfortunately, this study is not currently seeking participants. Although the trial was last updated on February 8th of this year, it originally posted over a year ago on March 2nd 2021. However, there are 1128 other trials which are still recruiting patients."

Answered by AI

How can I sign up for this opportunity to help test a new medical treatment?

"Up to 32 individuals that have difficulty losing weight, aged 18-45, can sign up for this trial. The ideal candidate is overweight or obese (BMI 25-45 kg/m2), not currently engaged in any exercise or weight loss activities, has no cardiac, pulmonary, or metabolic health conditions, able to safely engage in exercise, and if female participants must be premenopausal and not pregnant or nursing."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
Pennsylvania
Texas
How old are they?
65+
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~8 spots leftby Mar 2025